Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1977 Oct;40(10):979–981. doi: 10.1136/jnnp.40.10.979

Increased myofibrillar protein catabolism in Duchenne muscular dystrophy measured by 3-methylhistidine excretion in the urine.

R O McKeran, D Halliday, P Purkiss
PMCID: PMC492880  PMID: 591977

Abstract

Myofibrillar protein catabolic rate was calculated in seven patients with Duchenne muscular dystrophy from the amount of 3-methylhistidine excreted in the urine, and found to be over three times that found in a control series when expresses as the percentage of myofibrillar protein catabolised per day. It is suggested that measurement of myofibrillar protein catabolic rate may add a useful parameter in the study of muscle disorders.

Full text

PDF
979

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asatoor A. M., Armstrong M. D. 3-methylhistidine, a component of actin. Biochem Biophys Res Commun. 1967 Jan 23;26(2):168–174. doi: 10.1016/0006-291x(67)90229-x. [DOI] [PubMed] [Google Scholar]
  2. Bank W. J., Rowland L. P., Ipsen J. Amino acids of plasma and urine in diseases of muscle. Arch Neurol. 1971 Feb;24(2):176–186. doi: 10.1001/archneur.1971.00480320104011. [DOI] [PubMed] [Google Scholar]
  3. EDWARDS K. D., WHYTE H. M. The measurement of creatinine in plasma and urine. Aust J Exp Biol Med Sci. 1958 Aug;36(4):383–394. doi: 10.1038/icb.1958.41. [DOI] [PubMed] [Google Scholar]
  4. Halliday D., McKeran R. O. Measurement of muscle protein synthetic rate from serial muscle biopsies and total body protein turnover in man by continuous intravenous infusion of L-(alpha-15N)lysine. Clin Sci Mol Med. 1975 Dec;49(6):581–590. doi: 10.1042/cs0490581. [DOI] [PubMed] [Google Scholar]
  5. Haverberg L. N., Omstedt P. T., Munro H. N., Young V. R. Ntau-methylhistidine content of mixed proteins in various rat tissues. Biochim Biophys Acta. 1975 Sep 9;405(1):67–71. doi: 10.1016/0005-2795(75)90315-3. [DOI] [PubMed] [Google Scholar]
  6. Ionasescu V. Distinction between Duchenne and other muscular dystrophies by ribosomal protein synthesis. J Med Genet. 1975 Mar;12(1):49–54. doi: 10.1136/jmg.12.1.49. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Ionasescu V., Zellweger H., Conway T. W. A new approach for carrier detection in Duchenne muscular dystrophy. Protein synthesis of muscle polyribosomes in vitro. Neurology. 1971 Jul;21(7):703–709. doi: 10.1212/wnl.21.7.703. [DOI] [PubMed] [Google Scholar]
  8. Ionasescu V., Zellweger H., McCormick W. F., Conway T. W. Comparison of ribosomal protein synthesis in Becker and Duchenne muscular dystrophies. Neurology. 1973 Mar;23(3):245–253. doi: 10.1212/wnl.23.3.245. [DOI] [PubMed] [Google Scholar]
  9. Long C. L., Haverberg L. N., Young V. R., Kinney J. M., Munro H. N., Geiger J. W. Metabolism of 3-methylhistidine in man. Metabolism. 1975 Aug;24(8):929–935. doi: 10.1016/0026-0495(75)90084-0. [DOI] [PubMed] [Google Scholar]
  10. RYAN R. J., WILLIAMS J. D., ANSELL B. M., BERNSTEIN L. M. The relationship of body composition to oxygen consumption and creatinine excretion in healthy and wasted men. Metabolism. 1957 Jul;6(4):365–377. [PubMed] [Google Scholar]
  11. Young V. R., Alexis S. D., Baliga B. S., Munro H. N., Muecke W. Metabolism of administered 3-methylhistidine. Lack of muscle transfer ribonucleic acid charging and quantitative excretion as 3-methylhistidine and its N-acetyl derivative. J Biol Chem. 1972 Jun 10;247(11):3592–3600. [PubMed] [Google Scholar]
  12. Young V. R., Havenberg L. N., Bilmazes C., Munro H. N. Potential use of 3-methylhistidine excretion as an index of progressive reduction in muscle protein catabolism during starvation. Metabolism. 1973 Nov;23(2):1429–1436. doi: 10.1016/0026-0495(73)90257-6. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES